Critical issues related to transfersomes – novel vesicular system

• Autorzy: Vinod K. R. , Kumar M. S. , Anbazhagan S. , Sandhya S. , Saikumar P. , Rohit R. T. , Banji D.

Warianty tytułu

PL

Transferosomy – nowy system transportu leków

• Języki publikacji: EN

Abstrakty

EN

It has become increasingly apparent that vesicular drag delivery elicits modest possessions in drag targeting. Transfersomes are a form of elastic or deformable vesicle, which were first introduced in the early 1990s. Elasticity can be achieved by using an edge activator in the lipid bilayer stracture. Molecules greater than 500 Da normally do not cross the skin. This prevents epicutaneous delivery of the high molecular weight therapeutics as well as non-invasive trans-cutaneous immunisation. Transdermal route will always remain a lucrative area for drag delivery. With the advent of new categories of drugs like peptides this route has captured more focus to combat the problems related to their delivery through oral route. But the transdermal route is equally filled with the hopes and disappointments as the transport of drag through this route faces many problems especially for the large molecules. To answer this problem many approaches were adopted. One of the very recent approaches is the use of ultra-defonnable carrier systems (transfersomes). They have been used as drag carriers for a range of smali molecules, peptides, proteins and vaccines, both in vitro and in vivo. Transfersomes penetrate through the pores of stratum comeum which are smaller than its size and get into the underlying viable skin in intact form. This is because of its deformable nature. The aim of this article is explanation the formation of micelle and vesicles, various types of vesicles, specifically focusing on transfersomes.

PL

Wydaje się, że obecnie transport liposomowy nie jest zbyt wykorzystywany do celowego dostarczania leków. Transferosomy to rodzaj elastycznych i deformowalnych liposomów, które po raz pierwszy wprowadzono we wczesnych latach dziewięćdziesiątych ubiegłego wieku. Elastyczność struktury uzyskano, stosując aktywatory w zewnętrznej strukturze dwuwarstwy lipidowej. Cząsteczki o masie większej niż 500 Da nie przechodzą przez skórę. Zapobiega to dostarczaniu wysokocząsteczkowych leków przez naskórek oraz nieinwazyjnemu szczepieniu przezskómemu. Bezpośredni transport przez skórę jest najlepszym sposobem dostarczania leków. Wraz z pojawianiem się nowych kategorii leków, np. peptydów, dostarczanie leków przez skórę budzi coraz większe zainteresowanie, między innymi dzięki uniknięciu problemów występujących w dawkowaniu doustnym. Dostarczanie przez skórę wiąże się z wieloma nadziejami i rozczarowaniami, szczególnie w odniesieniu do dużych molekuł. Aby przezwyciężyć problemy, podjęto wiele badań w celu ich rozwiązania. Jednym z ostatnio stosowanych sposobów jest wykorzystanie super deformowalnych systemów transportu - transferosomów. Używane są one jako transportery wielu małych cząsteczek, peptydów, białek i szczepionek, zarówno in vivo, jak i in vitro. Tranferosomy penetrują pory stratum comeum, które są mniejsze od wymiarów samych transferosomów, a dzięki elastycznej naturze dostają się do głębszych warstw skóry w formie niezmienionej. Celem pracy jest wyjaśnienie powstawania miceli oraz różnego rodzaju liposomów ze szczególnym uwzględnieniem transferosomów.

Słowa kluczowe

EN

transfersome; novel vesicular system; vesicular transport; micelle; vesicle; sonication; confocal laser scanning microscopy; drug; drug transport

• Wydawca: -
• Czasopismo: Acta Scientiarum Polonorum. Technologia Alimentaria
• Rocznik: 2012
• Tom: 11
• Numer: 1
• Opis fizyczny: p.67-82,fig.,ref.

Twórcy

autor

Vinod K. R.

• HOD, Department of Pharmaceutics, Nalanda College of Pharmacy, Hyderabad Main Road, Nalgonda 508001, A.P., India

autor

Kumar M. S.

autor

Anbazhagan S.

autor

Sandhya S.

autor

Saikumar P.

autor

Rohit R. T.

autor

Banji D.

Bibliografia

• Allen J.M., 1984. In: Liposome technology. Vol. 1. Ed. G. Gregoriadis. CRC Press, Boca Raton, Florida, 109-122.
• Arulsudar N., Subramanian N., Mishra P., Chuttani K., Sharma R.K., Murthy R.S.R., 2004. Preparation, characterization, and biodistribution study of Technetium-99m - labeled leuprolide acetate-loaded liposomes in ehrlich ascites tumor-bearing mice. AAPS Pharm Sci. 6 (1).
• Babizhayev M.A., 1988. The biphasic effect of calcium on lipid peroxidation. Arch. Biochem. Biophys. 266, 446.
• Bangham A.D., Standish M.M., Watkins J.C., 1965. Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol. 13, 238-252.
• Barenholzt Y., Amselem S., Lichtenberg D., 1979. A new method for preparation of phospholipid vesicles (liposomes) - French press. FEBS Lett. 99, 210-214.
• Barrat J.L., Flansen J.P., 2003. Basic concepts for simple and complex liquids. Cambridge Univ. Press New York.
• Bhatia A., Kumar R., 2004. Tamoxifen in topical liposomes: development, characterization and in vitro evaluation. J. Pharm. Sci. 7 (2), 252-259.
• Blume G., Cevc G., 1993. Molecular mechanism of the lipid vesicle longevity invivo. Biochim. Biophys. Acta 1146, 157.
• Bommannan D., Potts R.O., Guy R.H., 1990. Examination of stratum comeum barrier function in vivo by infrared spectroscopy. J. Invest. Dermatol. 95, 403-408.
• Cevc G., 1991. Isothermal lipid phase. Trans. Chem. Phys. Lipids 57, 293-299.
• Cevc G., 1996. Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. Critical review. Ther. Drug Carrier Syst. 13, 257-388.
• Cevc G., Blume G., 1992. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim. Biophys. Acta 1104, 226-232.
• Cevc G., Blume G., Schatzlein A., 1997. Transfersomesmediated transepidermal delivery improves the regiospecificity and biological activity of corticosteroids in vivo. J. Contr. Releas. 45, 211-226.
• Cevc G., Grbauer D., Schatzlein A., Blume G., 1998. Ultraflexible vesicles. Transfersomes, have on extremely Iow pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochem. Acta 1368, 201-215.
• Cevc G., Lipowsky R., Sackman E., 2009. Material transport across permeability barrier by means of lipid vesicles. In: Handbook of biological physics. Vol. 1, 467, 474.
• Chandler D., 1987. Introduction to modem statistical mechanics. Oxford Univ. Press New York.
• Cuppoletti J., Mayhew E., Zobcl C.R., Jung C.Y., 1981. Erythrosomes: large proteoliposomes derived from crosslinked human erythrocyte cytoskeletons and exogenous lipid. Proc. Natil. Acad. Sci. USA 78, 2786.
• Deamer D.W., 1984. In: Liposome technology. Vol. 1. Ed. G. Gregoriadis. CRC Press, Boca Raton, Florida, 29-35.
• De Gennes P.G., 1979. Micelle formation and the hydrophobic effect. J. Phys. Lett. (Paris) 40, L69-L72.
• Di Bei, Marszalek J., Youan Bi-Botti C., 2009. Formulation of dacarbazine-loaded cubosomes. Part 1. Influence of formulation variables. AAPS Pharm. Sci. Tech. 10, 3, 1032-1033.
• Duangjit S., 2010. Characterization and in vitro skin permeation of meloxicam-loaded liposomes versus transfersomes. J. Drug Del. 1-9.
• Dubey V., Mishra D., Asthana A., Jain N., 2006. Transdermal delivery of a pineal hormone: Melatonin via elastic liposomes. Biomaterials 27, 3491-3496.
• Elmi M.M., Sarbolouki M.N., 2001. A simple method for preparation of immuno-magnetic liposomes. Int. J. Pharm. 215,45.
• Encyclopedia of controlled drug delivery. Vol. 1. 1999. Ed. E. Mathiowitz. John Wiley New York.
• Enoch H.G., Strittmatter R, 1979. Formation and properties of 1000 - A°-diameter, single - bilayer phospholipid vesicles. Proc. Natl. Acad. Sci. U.S.A. 76, 145-149.
• Escobar-Chávez J.J., Quintanar-Guerrero D., Ganem-Quintanar A., 2005. In vivo skin permeation of sodium naproxen formulated in PF-127 gels: Effect of Azone® and Transcutol®. Drug Develop. Ind. Pharm. 31, 447-454.
• Felgner P.L., Ringold G.M., 1994. Cationic liposome-mediated transfection. Nature 337, 387.
• Fry D.W., White J.C., Goldman I.D., 1978. Rapid separation of low molecular weight solutes from liposomes without dilution. J. Anal. Biochem. 90, 809-815.
• Gamal M., Maghraby M., Williams A.C., Barry B.W., Ganial M., Maghraby M., Williams A.C., Barry B.W., 1999. Skin delivery of Oestradiol from deformable and traditional liposomes. J. Pharm. Pharmacol. 51, 1123-1134.
• Ghada M.E. Zaafarany, Gehanne A.S. Awad, Samar M. Holayel, Nahed D. Mortada, 2010. Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int. J. Pharmaceutics 7, 34-37.
• Godin B., Touitou E., 2003. Ethosomes: new prospects in transdermal delivery. Crit. Rev. Ther. Drug Carr. Syst. 20, 63.
• Górnicki A., 2003. The influence of oxidative stress on microviscosity of hemoglobin-containing liposomes. Gen. Physiol. Biophys. 22, 121.
• Gregoriadis G., Ryman B.E., 1972 a. Fate of protein containing liposomes injected into rats. Eur. J. Biochem. 24, 485-491.
• Gregoriadis G., Rynlan B.E., 1972 b. Lysosomal localization of betafructofuranosidase - containing liposomes injected into rats. Biochem. J. 129, 123-133.
• Gruner S.M., Lenk R.P., Janoff A.S., Ostro M.J., 1985. Novel multilayered lipid vesicles: Comparison of physical characteristics of multilamellar liposomes and stable pleurilamellar vesicles. Biochemistry 24, 2833-2842.
• Hafer C., Goble R., Deering P., Lehmer A., Breut J., 1999. Formulation of interleukin-2 and interferon-a containing ultra deformable carrier for potential transdermal application. Anticancer Res. 19 (2c), 1505-1512.
• Higo N., Naik A., Bommannan D.B., Potts R.O., Guy R.H., 1993. Validation of reflectance infrared spectroscopy as a quantitative method to measure percutaneous absorption in vivo. Pharm. Res. 10, 1500-1505.
• Hofland H.E.J., Bouwstra J.A., Spies F., Gooris G., Nagelkerke J.F., 1994. Interaction of liposomes and niosomes with human skin. J. Pharm. Sci. 83, 1192-1196.
• Hope M.J., Bally M.B., Webb G., Cullis P.R., 1985. Production of large unilamellar vesicles by a rapid extrusion procedure: Characterization of size, trapped volume and ability to maintain a membrane potential. Biochim. Biophys. Acta 812, 55-65.
• Huang D.M., Chandler D.J., 2002. The hydrophobic effect and the influence of solute-solvent attractions. Phys. Chem. B, 106, 2047-2053.
• Huckriede A., Bungener L., Daemen T., Wilschut J., 2003. Influenza virosomes in vaccine development. Methods Enzymol. 373, 74.
• Israelachvili J.N., 1991. Intermolecular and surface forces. Academic Press London, 366-393.
• Jadoul A., Preat V., 1997. Electrically-enhanced transdermal delivery of domperidone. Int. J. Pharm. 154, 229-234.
• Jain N.K., 2001. Advances in controlled and novel drug delivery. CBS Publ. Distrib. New Delhi, 426-451.
• Jain S., Mishra D., Kuksał A., Tiwary A.K., Jain N.K., 2011. Vesicular approach for drug delivery into or across the skin: current status and future prospects. [online] www. Pharmainfo.net. as on 1708/2011.
• Jain S., Sapee R., Jain N.K., 1998. Ultraflexible lipid vesicles for effective transdermal delivery of norgesterol. In: Proceedings of 25th Conference of C.R.S. USA, 32-35.
• Kavitha D., Naga Sowjanya J., Panaganti S., 2010. Pharmacosomes: An emerging vesicular system. Int. J. Pharm. Sci. Rev. Res. 5, 168-171.
• Khopade A.J., Jain S., Jain N.K., 2002. Development of hemoglobin aquasomes from spherical hydroxyl apatite cores precipitated in the presence of half-generation poly(amidoamine) dendrimer. Int. J. Pharm. 241 (1), 145-154.
• King C.S., Barton S.P., Nicholls S., Marks R., 1979. The change in properties of the stratum comeum as a function of depth. Br. J. Dennatol. 100, 165-172.
• Kisak E.T., Coldren B., Evans C.A., Boyer C., Zasadziński J.A., 2004. The vesosome: a multicompartment drug delivery vehicle. Curr. Med. Chem. 11, 199.
• Kretschmar M., Amselem S., Zawoznik E., Mosbach K., Dietz A., Hof H., Nichterlein T., 2001. Efficient treatment of murine systemie infection with candida albicans using amphotericin-B incorporated in nanosize range particles (emulsomes). Mycoses 44, 7-8, 281-286.
• Krishnan L., Sad S., Patel G.B., Sprott G.D., 2001. The potent adjuvant activity of archaeosomes correlates to the recruitment and activation of macrophages and dendritic cells in vivo. J. Immunol. 166, 1885.
• Logan I.R., Sapountzi V., Gaughan L., Neal D.E., Robson C.N., 2004. Control of human PIRH2 protein stability: involvement of the TIP60 and the proteasome. J. Biol. Chem. 279, 11696.
• Lotte C., Wester R.C., Rougier A., Maibach H.I., 1993. Racial dififerences in the in vivo percutaneous absorption of some organie compounds: a comparison between black, Caucasian and Asian subjeets. Arch. Dermatol. Res. 284, 456-459.
• Lum K., Chandler D., Weeks J.D., 1999. Hydrophobicity at smali and large length scales. J. Phys. Chem. B, 103, 4570-4577.
• Maghraby E.I., Williams M., Barry B.W., 1998. Optimization of deformable vesicles for epidermal delivery of oestradiol. J. Pharm. Pharmacol. 50, 146.
• Mayer L.D., Hope M.J., Cullis P.R., Janoff A.S., 1986. Solute distributions and trapping efificiencies observed in freeze-thawed multilamellar vesicles. Biochim. Biophys. Acta 817, 193-196.
• Mitragotri S., Kost J., 2003. Ultrasound-mediated transdermal drug delivery. In: Modified release drug delivery technology. Eds J.M. Rathbone, J. Hadgraft, M.S. Roberts. Marcel Dekker New York, 561-571.
• Ohman H., Vahlquist A., 1994. In vivo studies conceming a pH gradient in human stratum comeum and upper epidermis. Acta Derm. Venereol. (Stockh) 74, 375-379.
• Patel R., 2009. Development and characterization of curcumin loaded transfersome for transdermal delivery. J. Pharm. Sci. Res. 1 (4), 71-80.
• Paul A., Cevec G., 1998. Non-invasive administration of protein antigens, epicutaneous with bovin serum albumin. Vaccine Res. 4, 145-164.
• Paul A., Cevec G., Bachhavat B.K., 1995. Transdermal immunization with large proteins by means of ultra deformable dmg carriers. Eur. J. Immunol. 25, 3551-3524.
• Pershing L.K., Silver B.S., Kmeger G.G., Shah V.P., Skelley J.P., 1992. Feasibility of measuring the bioavailability of topical betamethasone dipropionate in commercial formulations using dmg content in skin and a skin blanching bioassay. Pharm. Res. 9, 45-51.
• Petit-Frére C., Clingen P.H., Grewe M., Krutmann J., Roza L., Arlett C.F., 1998. Induction of interleukin-6 production by ultraviolet radiation in normal human epidermal keratinocytes and in a human keratinocyte celi line is mediated by DNA damage. J. Invest. Dermatol. 111 (3), 354-359.
• Pinkus H., 1951. Examination of the epidermis by the strip method of removing homy layers. I. Observation on thickness of the homy layer, and on mitotic activity after stripping. J. Invest. Dermatol. 16, 383-386.
• Planas M.E., Gonzalez P., Rodriguez S., Sanchez G., Cevc G., 1992. Non invasive percutaneous induction of topical analgesia by a new type of drug carrier and prolongation of local paini insensitivity by anesthetic liposomes. Anesthia Analog. 615-621.
• Planas M.E., Gonzalez R, Rodriguez S., Sanchez G., Cevc G., 2008. Non invasive percutaneous induction of topical analgesia by a new type of drug carrier, and prolongation of local pain insensitivity by anesthetic liposomes. Anesth. Analg. 615-621.
• Plautz G.E., 1993. Immunotherapy of malignancy by in vivo gene transfer into tumors. Proc. Natl. Acad. Sci. USA 90, 4645.
• Popovici A., 1986. Lipozomii - vectori medicamentosi. Farmacia 34 (1), 1-22.
• Porfire A.S., Parvu A.E., Daicoviciu D., Leucuţa S.E., 2009. Evaluation of antiinflamatory activity of liposome encapsulated superoxide dismutase in rats peritonitis. Farmacja 57 (4) 412-423.
• Qvist M.H., Hoeck U., Kreilgaard B., Madsen F., Hovgaard L., Frokjaer S., 2002. Application of confocal laser scanning microscopy in characterization of chemical enhancers in drug-in-adhesive transdermal patches. A APS Pharm. Sci. 4 (1), 11-18.
• Rougier A., Dupuis D., Lotte C., Roguet R., Wester R.C., 1986. Maibach HI. Regional variation in percutaneous absorption in man: measurement by the stripping method. Arch. Dermatol. Res. 278, 465-469.
• Schatzlein A., Cevc G., 1995. Skin penetration by phospholipids vesicles. Transfersomes as visualized by means of the Confocal Scanning Laser Microscopy, in characterization, etabolism, and novel biological applications. AOCS Press Champaign, 191-209.
• Sheth N.V., McKeough M.B., Spruance S.L., 1987. Measurement of the stratum comeum dmg reservoir to predict the therapeutic efficacy of topical iododeoxyuridine for herpes simplex vims infection. J. lnvest. Dermatol. 89, 598-602.
• Shivanand P., Manish G., Viral D., Jarina F., 2009. Transferosomes: A novel approach for transdermal dmg delivery. Schol. Res. Libr. Pharm. Lettr. 1 (2), 143-150.
• Stillinger F.H., 1983. Variational model for micelle structure. J. Chem. Phys. 78, 4654-4661.
• Strittmatter P., Enoch H.G., 1978. Formation and properties of 1000-A-diameter, single-bilayer phospholipid vesicles. Methods Enzymol. 52, 188-193.
• Sullivan S.M., Huang L., 1986. Enhanced delivery to target cells by heat-sensitive immunoliposomes. Proc. Natl. Acad. Sci. 83, 6117.
• Tanford C., 1980. The hydrophobic effect: Formation of micelles and biological membranes. Wiley Publ. New York.
• Targeting of drugs: Strategies for stealth therapeutic Systems. 1998. Eds G. Gregoriadis, B. McCormack. Plenum New York.
• Tojo K., Lee A.C., 1989. A method for prediction of steadystate of skin penetration in vivo. J. lnvest. Dermatol. 92, 105-108.
• Trotta M., 2004. Deformable liposomes for dermal administration of methotrexate. Int. J. Pharm. 270, 119-125.
• Vinod K.R., Sandhya S., Chandrashekar J., Swetha R., RajeshwarT., Banji D., Anbuazhagan S., 2010. Areview on genesis and characterization of phytosomes. Int. J. Pharm. Sci. Rev. Res. 4 (3), 69-75.
• Vyas S.P., Jaitely V.,KanujaP., 1997. Lipoproteins: theirpotential as endogenous target oriented novel drug delivery system. Indian J. Exp. Biol. 35, 212.
• Woo H.J., Carraro C., Chandler D., 1996. Assembly of extended interfaces and micelles: Charge frustrated models of amphiphilic mixtures. Faraday Discuss. 104, 183-191.
• Zhdanov R.I., Podobed O.V., Vlassov V.V., 2002. Cationic lipid-DNA complexes-lipoplexes-for gene transfer and therapy. Bioelectrochemistry 58, 53.